Publisher’s note: The advice in this consensus is now out of date. Please see updated joint guidance from PCDS and ABCD, available here.
The PDF of this publication remains online for archival purposes. Please refer to the current version for up-to-date recommendations.
Advice on selecting alternative glucose-lowering therapies when GLP-1 RAs used in the management of type 2 diabetes in adults are unavailable.
22 Mar 2024